Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome

BACKGROUND: Macrophage activation syndrome (MAS) is a potentially fatal complication of systemic inflammation. HMGB1 is a nuclear protein released extracellularly during proinflammatory lytic cell death or secreted by activated macrophages, NK cells, and additional cell types during infection or ste...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmblad, Karin, Schierbeck, Hanna, Sundberg, Erik, Horne, Anna-Carin, Erlandsson Harris, Helena, Henter, Jan-Inge, Andersson, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111379/
https://www.ncbi.nlm.nih.gov/pubmed/33975537
http://dx.doi.org/10.1186/s10020-021-00308-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111379/
https://www.ncbi.nlm.nih.gov/pubmed/33975537
http://dx.doi.org/10.1186/s10020-021-00308-0

Ejemplares similares